nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—BMPR2—artery—Kawasaki disease	0.0195	0.0352	CbGeAlD
Ruxolitinib—PRKG2—heart—Kawasaki disease	0.015	0.027	CbGeAlD
Ruxolitinib—PRKCE—heart—Kawasaki disease	0.014	0.0252	CbGeAlD
Ruxolitinib—RPS6KA6—heart—Kawasaki disease	0.0134	0.0242	CbGeAlD
Ruxolitinib—PLK1—skin of body—Kawasaki disease	0.0131	0.0237	CbGeAlD
Ruxolitinib—JAK1—cardiac ventricle—Kawasaki disease	0.0131	0.0236	CbGeAlD
Ruxolitinib—JAK1—neck—Kawasaki disease	0.013	0.0235	CbGeAlD
Ruxolitinib—DAPK2—cardiac ventricle—Kawasaki disease	0.0125	0.0225	CbGeAlD
Ruxolitinib—JAK1—myocardium—Kawasaki disease	0.0123	0.0222	CbGeAlD
Ruxolitinib—DAPK2—myocardium—Kawasaki disease	0.0118	0.0212	CbGeAlD
Ruxolitinib—DAPK3—cardiac ventricle—Kawasaki disease	0.0117	0.0212	CbGeAlD
Ruxolitinib—PLK3—heart—Kawasaki disease	0.0112	0.0202	CbGeAlD
Ruxolitinib—DAPK3—myocardium—Kawasaki disease	0.011	0.0199	CbGeAlD
Ruxolitinib—BMPR2—cardiac ventricle—Kawasaki disease	0.011	0.0198	CbGeAlD
Ruxolitinib—CAMK1—heart—Kawasaki disease	0.0105	0.0189	CbGeAlD
Ruxolitinib—DYRK1A—myocardium—Kawasaki disease	0.0103	0.0187	CbGeAlD
Ruxolitinib—MARK2—heart—Kawasaki disease	0.0102	0.0183	CbGeAlD
Ruxolitinib—BMP2K—neck—Kawasaki disease	0.00974	0.0176	CbGeAlD
Ruxolitinib—TAOK2—heart—Kawasaki disease	0.00942	0.017	CbGeAlD
Ruxolitinib—MAP3K7—cardiac ventricle—Kawasaki disease	0.00882	0.0159	CbGeAlD
Ruxolitinib—TYK2—cardiac ventricle—Kawasaki disease	0.00866	0.0156	CbGeAlD
Ruxolitinib—JAK3—heart—Kawasaki disease	0.00865	0.0156	CbGeAlD
Ruxolitinib—JAK1—heart—Kawasaki disease	0.0086	0.0155	CbGeAlD
Ruxolitinib—DCLK1—heart—Kawasaki disease	0.0086	0.0155	CbGeAlD
Ruxolitinib—MKNK2—cardiac ventricle—Kawasaki disease	0.00855	0.0154	CbGeAlD
Ruxolitinib—IRAK1—cardiac ventricle—Kawasaki disease	0.00855	0.0154	CbGeAlD
Ruxolitinib—JAK1—skin of body—Kawasaki disease	0.00842	0.0152	CbGeAlD
Ruxolitinib—CAMK1D—heart—Kawasaki disease	0.00839	0.0151	CbGeAlD
Ruxolitinib—PHKG2—heart—Kawasaki disease	0.00834	0.015	CbGeAlD
Ruxolitinib—MAP3K7—myocardium—Kawasaki disease	0.0083	0.015	CbGeAlD
Ruxolitinib—RET—neck—Kawasaki disease	0.00828	0.0149	CbGeAlD
Ruxolitinib—DAPK2—heart—Kawasaki disease	0.0082	0.0148	CbGeAlD
Ruxolitinib—TYK2—myocardium—Kawasaki disease	0.00815	0.0147	CbGeAlD
Ruxolitinib—STK16—heart—Kawasaki disease	0.00807	0.0145	CbGeAlD
Ruxolitinib—MKNK2—myocardium—Kawasaki disease	0.00804	0.0145	CbGeAlD
Ruxolitinib—IRAK1—myocardium—Kawasaki disease	0.00804	0.0145	CbGeAlD
Ruxolitinib—HIPK2—heart—Kawasaki disease	0.00803	0.0145	CbGeAlD
Ruxolitinib—JAK2—cardiac ventricle—Kawasaki disease	0.00788	0.0142	CbGeAlD
Ruxolitinib—DAPK3—heart—Kawasaki disease	0.00771	0.0139	CbGeAlD
Ruxolitinib—CLK2—heart—Kawasaki disease	0.00764	0.0138	CbGeAlD
Ruxolitinib—MAP3K3—cardiac ventricle—Kawasaki disease	0.00759	0.0137	CbGeAlD
Ruxolitinib—JAK2—myocardium—Kawasaki disease	0.00741	0.0134	CbGeAlD
Ruxolitinib—ROCK1—heart—Kawasaki disease	0.0074	0.0133	CbGeAlD
Ruxolitinib—DYRK1A—heart—Kawasaki disease	0.00722	0.013	CbGeAlD
Ruxolitinib—BMPR2—heart—Kawasaki disease	0.00719	0.013	CbGeAlD
Ruxolitinib—MAP3K3—myocardium—Kawasaki disease	0.00714	0.0129	CbGeAlD
Ruxolitinib—BMPR2—skin of body—Kawasaki disease	0.00704	0.0127	CbGeAlD
Ruxolitinib—TAOK3—cardiac ventricle—Kawasaki disease	0.00692	0.0125	CbGeAlD
Ruxolitinib—TAOK3—myocardium—Kawasaki disease	0.00651	0.0117	CbGeAlD
Ruxolitinib—CAMK2G—heart—Kawasaki disease	0.00644	0.0116	CbGeAlD
Ruxolitinib—BMP2K—heart—Kawasaki disease	0.00644	0.0116	CbGeAlD
Ruxolitinib—LRRK2—heart—Kawasaki disease	0.00638	0.0115	CbGeAlD
Ruxolitinib—MAP3K2—heart—Kawasaki disease	0.00584	0.0105	CbGeAlD
Ruxolitinib—MAP3K7—heart—Kawasaki disease	0.00579	0.0104	CbGeAlD
Ruxolitinib—TYK2—heart—Kawasaki disease	0.00569	0.0103	CbGeAlD
Ruxolitinib—MKNK2—heart—Kawasaki disease	0.00561	0.0101	CbGeAlD
Ruxolitinib—IRAK1—heart—Kawasaki disease	0.00561	0.0101	CbGeAlD
Ruxolitinib—TYK2—skin of body—Kawasaki disease	0.00557	0.01	CbGeAlD
Ruxolitinib—RET—heart—Kawasaki disease	0.00547	0.00987	CbGeAlD
Ruxolitinib—JAK2—heart—Kawasaki disease	0.00517	0.00933	CbGeAlD
Ruxolitinib—JAK2—skin of body—Kawasaki disease	0.00507	0.00913	CbGeAlD
Ruxolitinib—MAP3K3—heart—Kawasaki disease	0.00499	0.00899	CbGeAlD
Ruxolitinib—MAP3K3—skin of body—Kawasaki disease	0.00488	0.0088	CbGeAlD
Ruxolitinib—TAOK3—heart—Kawasaki disease	0.00455	0.00819	CbGeAlD
Ruxolitinib—PLK1—Mitotic M-M/G1 phases—CENPU—Kawasaki disease	0.00348	0.00782	CbGpPWpGaD
Ruxolitinib—BMPR2—Heart Development—VEGFA—Kawasaki disease	0.00345	0.00775	CbGpPWpGaD
Ruxolitinib—PRKCE—PDGFR-beta signaling pathway—BLK—Kawasaki disease	0.00344	0.00772	CbGpPWpGaD
Ruxolitinib—ROCK1—Focal Adhesion—ITGAE—Kawasaki disease	0.0033	0.00742	CbGpPWpGaD
Ruxolitinib—DYRK1A—Cell Cycle—CENPU—Kawasaki disease	0.00327	0.00734	CbGpPWpGaD
Ruxolitinib—JAK3—IL4-mediated signaling events—IL10—Kawasaki disease	0.00324	0.00727	CbGpPWpGaD
Ruxolitinib—JAK1—IL-6 signaling pathway—CRP—Kawasaki disease	0.00314	0.00705	CbGpPWpGaD
Ruxolitinib—HIPK2—C-MYB transcription factor network—CD4—Kawasaki disease	0.0031	0.00695	CbGpPWpGaD
Ruxolitinib—JAK1—IL6-mediated signaling events—CRP—Kawasaki disease	0.00292	0.00656	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling events mediated by PTP1B—FCGR2A—Kawasaki disease	0.0029	0.00652	CbGpPWpGaD
Ruxolitinib—PLK1—Regulation of toll-like receptor signaling pathway—CD40—Kawasaki disease	0.00288	0.00647	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling events mediated by PTP1B—BLK—Kawasaki disease	0.00282	0.00632	CbGpPWpGaD
Ruxolitinib—JAK1—IL4-mediated signaling events—IL10—Kawasaki disease	0.00279	0.00626	CbGpPWpGaD
Ruxolitinib—RET—Aryl Hydrocarbon Receptor—VEGFA—Kawasaki disease	0.00272	0.0061	CbGpPWpGaD
Ruxolitinib—PLK1—Cell Cycle, Mitotic—CENPU—Kawasaki disease	0.0026	0.00585	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—ITPKC—Kawasaki disease	0.00256	0.00575	CbGpPWpGaD
Ruxolitinib—LRRK2—Allograft Rejection—VEGFA—Kawasaki disease	0.00254	0.00571	CbGpPWpGaD
Ruxolitinib—IRAK1—Apoptosis Modulation and Signaling—BLK—Kawasaki disease	0.00245	0.00549	CbGpPWpGaD
Ruxolitinib—PLK4—Cell Cycle, Mitotic—CENPU—Kawasaki disease	0.00243	0.00545	CbGpPWpGaD
Ruxolitinib—PLK1—Cell Cycle—CENPU—Kawasaki disease	0.00233	0.00523	CbGpPWpGaD
Ruxolitinib—TYK2—IL-6 signaling pathway—CRP—Kawasaki disease	0.00232	0.0052	CbGpPWpGaD
Ruxolitinib—RET—SIDS Susceptibility Pathways—IL10—Kawasaki disease	0.0023	0.00517	CbGpPWpGaD
Ruxolitinib—ROCK1—amb2 Integrin signaling—MMP9—Kawasaki disease	0.0023	0.00516	CbGpPWpGaD
Ruxolitinib—MAP3K7—IL-6 signaling pathway—CRP—Kawasaki disease	0.00225	0.00505	CbGpPWpGaD
Ruxolitinib—IRAK1—IL1 and megakaryotyces in obesity—MMP9—Kawasaki disease	0.00224	0.00503	CbGpPWpGaD
Ruxolitinib—MAP3K7—B Cell Receptor Signaling Pathway—BLK—Kawasaki disease	0.00219	0.00492	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—ITPKC—Kawasaki disease	0.00218	0.00489	CbGpPWpGaD
Ruxolitinib—PLK4—Cell Cycle—CENPU—Kawasaki disease	0.00217	0.00488	CbGpPWpGaD
Ruxolitinib—TYK2—IL6-mediated signaling events—CRP—Kawasaki disease	0.00216	0.00485	CbGpPWpGaD
Ruxolitinib—PLK3—Integrated Breast Cancer Pathway—VEGFA—Kawasaki disease	0.00215	0.00483	CbGpPWpGaD
Ruxolitinib—PRKCE—TCR signaling in naïve CD4+ T cells—CD4—Kawasaki disease	0.00207	0.00465	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling events mediated by TCPTP—VEGFA—Kawasaki disease	0.00204	0.00458	CbGpPWpGaD
Ruxolitinib—JAK1—VEGFR2 mediated cell proliferation—VEGFA—Kawasaki disease	0.002	0.00449	CbGpPWpGaD
Ruxolitinib—ROCK1—EPHA-mediated growth cone collapse—VEGFA—Kawasaki disease	0.00197	0.00442	CbGpPWpGaD
Ruxolitinib—JAK2—CXCR4-mediated signaling events—BLK—Kawasaki disease	0.00192	0.00431	CbGpPWpGaD
Ruxolitinib—TYK2—IL12-mediated signaling events—CCR5—Kawasaki disease	0.00191	0.00429	CbGpPWpGaD
Ruxolitinib—IRAK1—Toll-like Receptor Signaling Pathway—CD40—Kawasaki disease	0.00186	0.00417	CbGpPWpGaD
Ruxolitinib—PRKCE—LPA receptor mediated events—MMP9—Kawasaki disease	0.00185	0.00415	CbGpPWpGaD
Ruxolitinib—TYK2—IL23-mediated signaling events—CD4—Kawasaki disease	0.00176	0.00396	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling events mediated by TCPTP—VEGFA—Kawasaki disease	0.00176	0.00394	CbGpPWpGaD
Ruxolitinib—JAK2—IL-6 signaling pathway—CRP—Kawasaki disease	0.00176	0.00394	CbGpPWpGaD
Ruxolitinib—ROCK1—Focal Adhesion—BLK—Kawasaki disease	0.00176	0.00394	CbGpPWpGaD
Ruxolitinib—MAP3K7—Toll-like Receptor Signaling Pathway—CD40—Kawasaki disease	0.00175	0.00392	CbGpPWpGaD
Ruxolitinib—PRKCE—Oncostatin M Signaling Pathway—VEGFA—Kawasaki disease	0.00164	0.00368	CbGpPWpGaD
Ruxolitinib—JAK2—IL6-mediated signaling events—CRP—Kawasaki disease	0.00164	0.00367	CbGpPWpGaD
Ruxolitinib—MAP3K7—Downstream TCR signaling—CD4—Kawasaki disease	0.00158	0.00354	CbGpPWpGaD
Ruxolitinib—JAK2—IL4-mediated signaling events—IL10—Kawasaki disease	0.00156	0.0035	CbGpPWpGaD
Ruxolitinib—JAK3—SHP2 signaling—VEGFA—Kawasaki disease	0.00152	0.00341	CbGpPWpGaD
Ruxolitinib—HIPK2—Integrated Breast Cancer Pathway—VEGFA—Kawasaki disease	0.00151	0.0034	CbGpPWpGaD
Ruxolitinib—TYK2—VEGFR2 mediated cell proliferation—VEGFA—Kawasaki disease	0.00148	0.00332	CbGpPWpGaD
Ruxolitinib—IRAK1—Regulation of toll-like receptor signaling pathway—CD40—Kawasaki disease	0.00145	0.00325	CbGpPWpGaD
Ruxolitinib—JAK2—IL12-mediated signaling events—CCR5—Kawasaki disease	0.00145	0.00325	CbGpPWpGaD
Ruxolitinib—JAK2—S1P3 pathway—VEGFA—Kawasaki disease	0.00143	0.00321	CbGpPWpGaD
Ruxolitinib—JAK2—PDGFR-beta signaling pathway—BLK—Kawasaki disease	0.0014	0.00314	CbGpPWpGaD
Ruxolitinib—JAK3—Oncostatin M Signaling Pathway—VEGFA—Kawasaki disease	0.00138	0.00311	CbGpPWpGaD
Ruxolitinib—MAP3K7—Regulation of toll-like receptor signaling pathway—CD40—Kawasaki disease	0.00136	0.00306	CbGpPWpGaD
Ruxolitinib—MAP3K7—TWEAK Signaling Pathway—MMP9—Kawasaki disease	0.00135	0.00302	CbGpPWpGaD
Ruxolitinib—MAP3K7—TCR Signaling Pathway—CCR5—Kawasaki disease	0.00134	0.00301	CbGpPWpGaD
Ruxolitinib—JAK2—IL23-mediated signaling events—CD4—Kawasaki disease	0.00134	0.003	CbGpPWpGaD
Ruxolitinib—JAK1—SHP2 signaling—VEGFA—Kawasaki disease	0.0013	0.00293	CbGpPWpGaD
Ruxolitinib—ROCK1—AGE/RAGE pathway—MMP9—Kawasaki disease	0.00129	0.00289	CbGpPWpGaD
Ruxolitinib—BMPR2—Integrated Breast Cancer Pathway—VEGFA—Kawasaki disease	0.00129	0.00289	CbGpPWpGaD
Ruxolitinib—MAP3K7—B Cell Activation—BLK—Kawasaki disease	0.00125	0.00281	CbGpPWpGaD
Ruxolitinib—ROCK1—Integrins in angiogenesis—VEGFA—Kawasaki disease	0.0012	0.0027	CbGpPWpGaD
Ruxolitinib—TYK2—IL12-mediated signaling events—CD4—Kawasaki disease	0.0012	0.00269	CbGpPWpGaD
Ruxolitinib—JAK1—Oncostatin M Signaling Pathway—VEGFA—Kawasaki disease	0.00119	0.00267	CbGpPWpGaD
Ruxolitinib—MAP3K7—TCR signaling—CD4—Kawasaki disease	0.00118	0.00265	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—Kawasaki disease	0.00113	0.00254	CbGpPWpGaD
Ruxolitinib—JAK2—VEGFR2 mediated cell proliferation—VEGFA—Kawasaki disease	0.00112	0.00251	CbGpPWpGaD
Ruxolitinib—JAK2—Notch-mediated HES/HEY network—CD4—Kawasaki disease	0.0011	0.00248	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—FCGR2A—Kawasaki disease	0.00104	0.00234	CbGpPWpGaD
Ruxolitinib—RET—SIDS Susceptibility Pathways—VEGFA—Kawasaki disease	0.00102	0.0023	CbGpPWpGaD
Ruxolitinib—ROCK1—EPH-Ephrin signaling—MMP9—Kawasaki disease	0.000971	0.00218	CbGpPWpGaD
Ruxolitinib—PLK1—Integrated Breast Cancer Pathway—VEGFA—Kawasaki disease	0.000917	0.00206	CbGpPWpGaD
Ruxolitinib—JAK2—IL12-mediated signaling events—CD4—Kawasaki disease	0.000909	0.00204	CbGpPWpGaD
Ruxolitinib—MAP3K7—C-MYB transcription factor network—CD4—Kawasaki disease	0.000888	0.00199	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Axon guidance—MMP9—Kawasaki disease	0.000887	0.00199	CbGpPWpGaD
Ruxolitinib—TYK2—Oncostatin M Signaling Pathway—VEGFA—Kawasaki disease	0.000879	0.00197	CbGpPWpGaD
Ruxolitinib—ROCK1—EPH-Ephrin signaling—VEGFA—Kawasaki disease	0.000872	0.00196	CbGpPWpGaD
Ruxolitinib—MAP3K7—TCR Signaling Pathway—CD4—Kawasaki disease	0.000841	0.00189	CbGpPWpGaD
Ruxolitinib—JAK1—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	0.000799	0.0018	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Axon guidance—VEGFA—Kawasaki disease	0.000796	0.00179	CbGpPWpGaD
Ruxolitinib—ROCK1—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	0.000786	0.00177	CbGpPWpGaD
Ruxolitinib—PLK1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	0.00076	0.00171	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—FCGR2A—Kawasaki disease	0.000757	0.0017	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by VEGF—VEGFA—Kawasaki disease	0.000755	0.00169	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by VEGF—VEGFA—Kawasaki disease	0.000742	0.00167	CbGpPWpGaD
Ruxolitinib—JAK2—AGE/RAGE pathway—MMP9—Kawasaki disease	0.000733	0.00165	CbGpPWpGaD
Ruxolitinib—JAK2—SHP2 signaling—VEGFA—Kawasaki disease	0.00073	0.00164	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.000714	0.0016	CbGpPWpGaD
Ruxolitinib—JAK2—CXCR4-mediated signaling events—CD4—Kawasaki disease	0.000694	0.00156	CbGpPWpGaD
Ruxolitinib—JAK2—Oncostatin M Signaling Pathway—VEGFA—Kawasaki disease	0.000666	0.0015	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Developmental Biology—MMP9—Kawasaki disease	0.000633	0.00142	CbGpPWpGaD
Ruxolitinib—PRKCE—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	0.000616	0.00138	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—FCGR2A—Kawasaki disease	0.000607	0.00136	CbGpPWpGaD
Ruxolitinib—JAK1—Integrated Breast Cancer Pathway—VEGFA—Kawasaki disease	0.000607	0.00136	CbGpPWpGaD
Ruxolitinib—JAK2—CXCR4-mediated signaling events—MMP9—Kawasaki disease	0.000604	0.00136	CbGpPWpGaD
Ruxolitinib—TYK2—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	0.00059	0.00133	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—BLK—Kawasaki disease	0.000589	0.00132	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—FCGR2A—Kawasaki disease	0.000576	0.00129	CbGpPWpGaD
Ruxolitinib—PRKG2—Hemostasis—VEGFA—Kawasaki disease	0.000575	0.00129	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Developmental Biology—VEGFA—Kawasaki disease	0.000568	0.00128	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—FCGR2A—Kawasaki disease	0.000559	0.00125	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by VEGF—VEGFA—Kawasaki disease	0.000557	0.00125	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—FCGR2A—Kawasaki disease	0.000556	0.00125	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—FCGR2A—Kawasaki disease	0.000543	0.00122	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—FCGR2A—Kawasaki disease	0.000542	0.00122	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—CRP—Kawasaki disease	0.000541	0.00122	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—BLK—Kawasaki disease	0.000539	0.00121	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—CCR5—Kawasaki disease	0.000533	0.0012	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.000527	0.00118	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—BLK—Kawasaki disease	0.000527	0.00118	CbGpPWpGaD
Ruxolitinib—JAK3—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	0.00052	0.00117	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—FCGR2A—Kawasaki disease	0.000512	0.00115	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—BLK—Kawasaki disease	0.000505	0.00113	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—BLK—Kawasaki disease	0.000497	0.00112	CbGpPWpGaD
Ruxolitinib—ROCK1—Focal Adhesion—VEGFA—Kawasaki disease	0.000497	0.00112	CbGpPWpGaD
Ruxolitinib—CAMK2G—Cellular responses to stress—VEGFA—Kawasaki disease	0.00049	0.0011	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—CD40—Kawasaki disease	0.000489	0.0011	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—CCR5—Kawasaki disease	0.000482	0.00108	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—CD40—Kawasaki disease	0.000448	0.00101	CbGpPWpGaD
Ruxolitinib—JAK1—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	0.000447	0.001	CbGpPWpGaD
Ruxolitinib—JAK2—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	0.000447	0.001	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—FCGR2A—Kawasaki disease	0.000441	0.00099	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CD40—Kawasaki disease	0.000438	0.000983	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—BLK—Kawasaki disease	0.000428	0.00096	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—FCGR2A—Kawasaki disease	0.000423	0.000951	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by VEGF—VEGFA—Kawasaki disease	0.000422	0.000948	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—CD40—Kawasaki disease	0.000419	0.000942	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CD40—Kawasaki disease	0.000413	0.000928	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—CCR5—Kawasaki disease	0.000409	0.000918	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.000399	0.000897	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—CCR5—Kawasaki disease	0.000397	0.000892	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—CRP—Kawasaki disease	0.000393	0.000883	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—CCR5—Kawasaki disease	0.000374	0.000839	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—CCR5—Kawasaki disease	0.000371	0.000834	CbGpPWpGaD
Ruxolitinib—JAK1—Axon guidance—MMP9—Kawasaki disease	0.000367	0.000824	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—CD4—Kawasaki disease	0.000366	0.000821	CbGpPWpGaD
Ruxolitinib—ROCK1—Axon guidance—MMP9—Kawasaki disease	0.000361	0.00081	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CD40—Kawasaki disease	0.000355	0.000798	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—CCR5—Kawasaki disease	0.000345	0.000775	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—CCR5—Kawasaki disease	0.000338	0.000759	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—FCGR2A—Kawasaki disease	0.000335	0.000753	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—CD4—Kawasaki disease	0.000335	0.000752	CbGpPWpGaD
Ruxolitinib—JAK1—Axon guidance—VEGFA—Kawasaki disease	0.000329	0.00074	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—FCGR2A—Kawasaki disease	0.000325	0.000731	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—BLK—Kawasaki disease	0.000325	0.00073	CbGpPWpGaD
Ruxolitinib—ROCK1—Axon guidance—VEGFA—Kawasaki disease	0.000324	0.000728	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—VEGFA—Kawasaki disease	0.000318	0.000713	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—FCGR2A—Kawasaki disease	0.000316	0.000709	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—BLK—Kawasaki disease	0.000316	0.000709	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—CRP—Kawasaki disease	0.000315	0.000708	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—CCR5—Kawasaki disease	0.000313	0.000704	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—CCR5—Kawasaki disease	0.000313	0.000703	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—BLK—Kawasaki disease	0.000306	0.000688	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—CD4—Kawasaki disease	0.000303	0.00068	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—CRP—Kawasaki disease	0.000299	0.000671	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—CCR5—Kawasaki disease	0.000297	0.000667	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—CCR5—Kawasaki disease	0.000292	0.000656	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—CRP—Kawasaki disease	0.00029	0.000652	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—CRP—Kawasaki disease	0.000289	0.000649	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CRP—Kawasaki disease	0.000282	0.000634	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—CRP—Kawasaki disease	0.000281	0.000632	CbGpPWpGaD
Ruxolitinib—TYK2—Axon guidance—MMP9—Kawasaki disease	0.000271	0.000608	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CD40—Kawasaki disease	0.00027	0.000607	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—CCR5—Kawasaki disease	0.00027	0.000605	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—VEGFA—Kawasaki disease	0.000268	0.000602	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CRP—Kawasaki disease	0.000266	0.000598	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—CD4—Kawasaki disease	0.000266	0.000596	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—CCR5—Kawasaki disease	0.000265	0.000595	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD40—Kawasaki disease	0.000262	0.000589	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—MMP9—Kawasaki disease	0.000262	0.000588	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—MMP9—Kawasaki disease	0.000258	0.000578	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD40—Kawasaki disease	0.000254	0.000571	CbGpPWpGaD
Ruxolitinib—JAK2—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	0.00025	0.000562	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—FCGR2A—Kawasaki disease	0.000247	0.000554	CbGpPWpGaD
Ruxolitinib—TYK2—Axon guidance—VEGFA—Kawasaki disease	0.000243	0.000546	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—BLK—Kawasaki disease	0.000239	0.000537	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—VEGFA—Kawasaki disease	0.000235	0.000528	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—VEGFA—Kawasaki disease	0.000231	0.000519	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—VEGFA—Kawasaki disease	0.000231	0.000518	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CRP—Kawasaki disease	0.000229	0.000514	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—CCR5—Kawasaki disease	0.000227	0.000511	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CRP—Kawasaki disease	0.00022	0.000494	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—CCR5—Kawasaki disease	0.000219	0.000493	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—MMP9—Kawasaki disease	0.000217	0.000488	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—CD4—Kawasaki disease	0.000213	0.000478	CbGpPWpGaD
Ruxolitinib—JAK2—Axon guidance—MMP9—Kawasaki disease	0.000205	0.000461	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—MMP9—Kawasaki disease	0.000204	0.000459	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—CD4—Kawasaki disease	0.000202	0.000453	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—CCR5—Kawasaki disease	0.000199	0.000447	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD40—Kawasaki disease	0.000199	0.000446	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—CD4—Kawasaki disease	0.000197	0.000442	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—CD4—Kawasaki disease	0.000196	0.00044	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—CD4—Kawasaki disease	0.000195	0.000438	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—VEGFA—Kawasaki disease	0.000195	0.000438	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—MMP9—Kawasaki disease	0.000193	0.000434	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CD4—Kawasaki disease	0.000191	0.000428	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—CD4—Kawasaki disease	0.00019	0.000427	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CCR5—Kawasaki disease	0.000185	0.000416	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—MMP9—Kawasaki disease	0.000185	0.000415	CbGpPWpGaD
Ruxolitinib—JAK2—Axon guidance—VEGFA—Kawasaki disease	0.000184	0.000414	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—VEGFA—Kawasaki disease	0.000183	0.000412	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—CD4—Kawasaki disease	0.000183	0.00041	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CD4—Kawasaki disease	0.00018	0.000404	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CRP—Kawasaki disease	0.000174	0.000391	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—VEGFA—Kawasaki disease	0.000174	0.00039	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CRP—Kawasaki disease	0.000169	0.00038	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—CCR5—Kawasaki disease	0.000168	0.000377	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—CCR5—Kawasaki disease	0.000166	0.000373	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—VEGFA—Kawasaki disease	0.000166	0.000373	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CRP—Kawasaki disease	0.000164	0.000368	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ITPKC—Kawasaki disease	0.000162	0.000365	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CCR5—Kawasaki disease	0.000159	0.000358	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CCR5—Kawasaki disease	0.000157	0.000352	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CD4—Kawasaki disease	0.000155	0.000347	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CCR5—Kawasaki disease	0.000151	0.000339	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CD4—Kawasaki disease	0.000149	0.000334	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—MMP9—Kawasaki disease	0.000146	0.000329	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—CD4—Kawasaki disease	0.000143	0.000321	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—VEGFA—Kawasaki disease	0.000132	0.000295	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—VEGFA—Kawasaki disease	0.000129	0.00029	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CRP—Kawasaki disease	0.000128	0.000288	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CCR5—Kawasaki disease	0.000127	0.000286	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CCR5—Kawasaki disease	0.000121	0.000272	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—MMP9—Kawasaki disease	0.00012	0.000269	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CD4—Kawasaki disease	0.000118	0.000264	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CCR5—Kawasaki disease	0.000118	0.000264	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD4—Kawasaki disease	0.000114	0.000256	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CCR5—Kawasaki disease	0.000114	0.000256	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD4—Kawasaki disease	0.000111	0.000249	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—VEGFA—Kawasaki disease	0.000108	0.000242	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—CD4—Kawasaki disease	0.000105	0.000237	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—MMP9—Kawasaki disease	0.000101	0.000227	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—VEGFA—Kawasaki disease	9.09e-05	0.000204	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CCR5—Kawasaki disease	8.91e-05	0.0002	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—MMP9—Kawasaki disease	8.71e-05	0.000196	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD4—Kawasaki disease	8.65e-05	0.000194	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—MMP9—Kawasaki disease	8.56e-05	0.000192	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CD4—Kawasaki disease	7.99e-05	0.000179	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—VEGFA—Kawasaki disease	7.82e-05	0.000176	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—VEGFA—Kawasaki disease	7.69e-05	0.000173	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MMP9—Kawasaki disease	6.62e-05	0.000149	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MMP9—Kawasaki disease	6.43e-05	0.000144	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MMP9—Kawasaki disease	6.24e-05	0.00014	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—VEGFA—Kawasaki disease	5.95e-05	0.000134	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—VEGFA—Kawasaki disease	5.77e-05	0.00013	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—VEGFA—Kawasaki disease	5.6e-05	0.000126	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MMP9—Kawasaki disease	4.87e-05	0.000109	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—VEGFA—Kawasaki disease	4.37e-05	9.82e-05	CbGpPWpGaD
